| Year |
Citation |
Score |
| 2023 |
Martínez-Aguirre C, Márquez LA, Santiago-Castañeda CL, Carmona-Cruz F, Nuñez-Lumbreras MLA, Martínez-Rojas VA, Alonso-Vanegas M, Aguado-Carrillo G, Gómez-Víquez NL, Galván EJ, Cuéllar-Herrera M, Rocha L. Cannabidiol Modifies the Glutamate Over-Release in Brain Tissue of Patients and Rats with Epilepsy: A Pilot Study. Biomedicines. 11. PMID 38137458 DOI: 10.3390/biomedicines11123237 |
0.769 |
|
| 2023 |
Fonseca-Barriendos D, Castañeda-Cabral JL, Martínez-Cuevas F, Besio W, Valdés-Cruz A, Rocha L. Transcranial Focal Electric Stimulation Avoids P-Glycoprotein Over-Expression during Electrical Amygdala Kindling and Delays Epileptogenesis in Rats. Life (Basel, Switzerland). 13. PMID 37374077 DOI: 10.3390/life13061294 |
0.753 |
|
| 2021 |
Martínez-Aguirre C, Cinar R, Rocha L. Targeting Endocannabinoid System in Epilepsy: For Good or for Bad. Neuroscience. PMID 34923038 DOI: 10.1016/j.neuroscience.2021.12.013 |
0.371 |
|
| 2021 |
Fonseca-Barriendos D, Frías-Soria CL, Pérez-Pérez D, Gómez-López R, Borroto Escuela DO, Rocha L. Drug-Resistant Epilepsy: drug target hypothesis and beyond the receptors. Epilepsia Open. PMID 34542940 DOI: 10.1002/epi4.12539 |
0.307 |
|
| 2021 |
Frías-Soria CL, Pérez-Pérez D, Orozco-Suárez S, Rocha L. Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures. Seizure. PMID 33879386 DOI: 10.1016/j.seizure.2021.04.008 |
0.377 |
|
| 2020 |
Martínez-Aguirre C, Carmona-Cruz F, Velasco AL, Velasco F, Aguado-Carrillo G, Cuéllar-Herrera M, Rocha L. Cannabidiol Acts at 5-HT Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy. Frontiers in Behavioral Neuroscience. 14: 611278. PMID 33384591 DOI: 10.3389/fnbeh.2020.611278 |
0.753 |
|
| 2020 |
Pérez-Pérez D, Castañeda-Cabral JL, Orozco-Suárez S, Sotelo J, Besio W, Rocha L. Noninvasive transcranial focal stimulation affects the convulsive seizure-induced P-glycoprotein expression and function in rats. Epilepsy & Behavior : E&B. 115: 107659. PMID 33334719 DOI: 10.1016/j.yebeh.2020.107659 |
0.426 |
|
| 2020 |
Castañeda-Cabral JL, Colunga-Durán A, Ureña-Guerrero ME, Beas-Zárate C, Nuñez-Lumbreras MdlA, Orozco-Suárez S, Alonso-Vanegas M, Guevara-Guzmán R, Deli MA, Valle-Dorado MG, Sánchez-Valle V, Rocha L. Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy. Microvascular Research. 132: 104059. PMID 32798551 DOI: 10.1016/J.Mvr.2020.104059 |
0.417 |
|
| 2020 |
Castañeda-Cabral JL, Ureña-Guerrero ME, Beas-Zárate C, Colunga-Durán A, Nuñez-Lumbreras MdLA, Orozco-Suárez S, Alonso-Vanegas M, Guevara-Guzmán R, Deli MA, Rocha L. Increased expression of proinflammatory cytokines and iNOS in the neocortical microvasculature of patients with temporal lobe epilepsy. Immunologic Research. 68: 169-176. PMID 32542572 DOI: 10.1007/S12026-020-09139-3 |
0.452 |
|
| 2020 |
Rocha L, Cinar R, Guevara-Guzmán R, Alonso-Vanegas M, San-Juan D, Martínez-Juárez I, Castañeda-Cabral JL, Carmona-Cruz F. Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders. Frontiers in Behavioral Neuroscience. 14: 52. PMID 32435186 DOI: 10.3389/Fnbeh.2020.00052 |
0.464 |
|
| 2020 |
Vega-García A, Rocha L, Guevara-Guzmán R, Guerra-Araiza C, Feria-Romero I, Gallardo JM, Neri-Gomez T, Suárez-Santiago JE, Orozco-Suarez S. Magnolia Officinalis Reduces Inflammation And Damage Induced By Recurrent Status Epilepticus In Immature Rats Current Pharmaceutical Design. 26: 1388-1401. PMID 32196444 DOI: 10.2174/1381612826666200320121813 |
0.419 |
|
| 2020 |
Rocha L, Frías-Soria CL, Ortiz JG, Auzmendi J, Lazarowski A. Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? Epilepsia Open. 5: 36-49. PMID 32140642 DOI: 10.1002/epi4.12376 |
0.318 |
|
| 2019 |
Organista-Juárez D, Jiménez A, Rocha L, Alonso-Vanegas M, Guevara-Guzmán R. Differential expression of miR-34a, 451, 1260, 1275 and 1298 in the neocortex of patients with mesial temporal lobe epilepsy. Epilepsy Research. 157: 106188. PMID 31470144 DOI: 10.1016/J.Eplepsyres.2019.106188 |
0.314 |
|
| 2019 |
Enrique AV, Di Ianni ME, Goicoechea S, Lazarowski A, Valle-Dorado MG, Costa JJL, Rocha L, Girardi E, Talevi A. New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in mice. Epilepsy & Behavior : E&B. 121: 106451. PMID 31420290 DOI: 10.1016/j.yebeh.2019.106451 |
0.34 |
|
| 2019 |
Pérez-Pérez D, Frías-Soria CL, Rocha L. Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources. Epilepsy & Behavior. 106430. PMID 31378558 DOI: 10.1016/J.Yebeh.2019.07.031 |
0.436 |
|
| 2019 |
Navarrete-Modesto V, Orozco-Suárez S, Alonso-Vanegas M, Feria-Romero IA, Rocha L. REST/NRSF transcription factor is overexpressed in hippocampus of patients with drug-resistant mesial temporal lobe epilepsy. Epilepsy & Behavior. 94: 118-123. PMID 30903955 DOI: 10.1016/J.Yebeh.2019.02.012 |
0.44 |
|
| 2019 |
Navarrete-Modesto V, Orozco-Suárez S, Feria-Romero IA, Rocha L. The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs Epilepsy Research. 149: 53-65. PMID 30476813 DOI: 10.1016/J.Eplepsyres.2018.11.006 |
0.35 |
|
| 2019 |
Rocha L, Fonseca-Barrietos D, Alonso-Vanegas M, Carmona F, Martinez I. Frontal lobe epilepsy is associated with lower dopaminergic neurotransmission Ibro Reports. 6. DOI: 10.1016/J.Ibror.2019.07.758 |
0.444 |
|
| 2018 |
Mercado-Gómez OF, Córdova-Dávalos L, García-Betanzo D, Rocha L, Alonso-Vanegas MA, Cienfuegos J, Guevara-Guzmán R. Overexpression of inflammatory-related and nitric oxide synthase genes in olfactory bulbs from frontal lobe epilepsy patients. Epilepsy Research. 148: 37-43. PMID 30366204 DOI: 10.1016/J.Eplepsyres.2018.09.012 |
0.351 |
|
| 2018 |
Contreras-García IJ, Pichardo-Macías LA, Santana-Gómez CE, Sánchez-Huerta K, Ramírez-Hernández R, Gómez-González B, Rocha L, Mendoza Torreblanca JG. Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model. Epilepsy & Behavior : E&B. 88: 283-294. PMID 30336420 DOI: 10.1016/J.Yebeh.2018.08.023 |
0.373 |
|
| 2018 |
Santana-Gómez CE, Valle-Dorado MG, Domínguez-Valentín AE, Hernández-Moreno A, Orozco-Suárez S, Rocha L. Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus. Neurochemistry International. 120: 224-232. PMID 30213635 DOI: 10.1016/j.neuint.2018.09.004 |
0.362 |
|
| 2018 |
Valle-Dorado MG, Santana-Gómez CE, Orozco-Suárez SA, Rocha L. Sodium cromoglycate reduces short- and long-term consequences of status epilepticus in rats. Epilepsy & Behavior. 87: 200-206. PMID 30115604 DOI: 10.1016/J.Yebeh.2018.06.021 |
0.457 |
|
| 2018 |
Cuellar-Herrera M, Rocha L, Saleh-Subaie N, Velasco F, Aguado-Carrillo G, Alonso-Vanegas M, Guevara-Guzmán R, Velasco AL. Changes in functional coupling of 5-HT1A receptor to the G-protein in neocortex temporal tissues of patients with temporal lobe epilepsy Revista MéDica Del Hospital General De MéXico. 81: 177-183. DOI: 10.1016/J.Hgmx.2017.07.002 |
0.783 |
|
| 2017 |
Lara-Valderrábano L, Galván EJ, Rocha L. Propylparaben suppresses epileptiform activity in hippocampal CA1 pyramidal cells in vitro. Epilepsy Research. 136: 126-129. PMID 28843182 DOI: 10.1016/J.Eplepsyres.2017.08.006 |
0.395 |
|
| 2017 |
Santana-Gómez CE, Orozco-Suárez SA, Talevi A, Bruno-Blanch L, Magdaleno-Madrigal VM, Fernández-Mas R, Rocha L. Propylparaben applied after pilocarpine-induced status epilepticus modifies hippocampal excitability and glutamate release in rats. Neurotoxicology. PMID 28174044 DOI: 10.1016/j.neuro.2017.01.009 |
0.767 |
|
| 2017 |
Enrique A, Goicoechea S, Castaño R, Taborda F, Rocha L, Orozco S, Girardi E, Blanch LB. New model of pharmacoresistant seizures induced by 3-mercaptopropionic acid in mice. Epilepsy Research. 129: 8-16. PMID 27875747 DOI: 10.1016/J.Eplepsyres.2016.10.012 |
0.45 |
|
| 2017 |
Torre ARdl, Rocha L, Salgado-Ceballos H, Casillas PEG, Luna-Bárcenas G. Nanotechnology as Potential Strategy for the Treatment of Pharmacoresistant Epilepsy and Comorbid Psychiatric Disorders. Mini-Reviews in Medicinal Chemistry. 17: 237-246. PMID 27739360 DOI: 10.2174/1389557516666161013105000 |
0.436 |
|
| 2016 |
Bañuelos-Cabrera I, Cuéllar-Herrera M, Velasco AL, Velasco F, Alonso-Vanegas M, Carmona F, Guevara R, Arias-Montaño JA, Rocha L. Pharmacoresistant temporal lobe epilepsy modifies histamine turnover and H3 receptor function in the human hippocampus and temporal neocortex. Epilepsia. PMID 26915454 DOI: 10.1111/Epi.13329 |
0.769 |
|
| 2015 |
Santana-Gomez CE, Alcantara-Gonzalez D, Luna-Munguia H, Banuelos-Cabrera I, Magdaleno-Madrigal V, Tamayo M, Rocha LL, Besio WG. Transcranial focal electrical stimulation reduces seizure activity and hippocampal glutamate release during status epilepticus. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2015: 6586-9. PMID 26737802 DOI: 10.1109/EMBC.2015.7319902 |
0.745 |
|
| 2015 |
Martínez-Levy GA, Rocha L, Lubin FD, Alonso-Vanegas MA, Nani A, Buentello-García RM, Pérez-Molina R, Briones-Velasco M, Recillas-Targa F, Pérez-Molina A, San Juan Ortra D, Cienfuegos J, Cruz-Fuentes CS. Increased expression of BDNF transcript with exon VI in hippocampus of patients with pharmaco-resistant Temporal Lobe Epilepsy. Neuroscience. PMID 26621122 DOI: 10.1016/j.neuroscience.2015.11.046 |
0.316 |
|
| 2015 |
Santana-Gómez CE, Alcántara-González D, Luna-Munguía H, Bañuelos-Cabrera I, Magdaleno-Madrigal V, Fernández-Mas R, Besio W, Rocha L. Transcranial focal electrical stimulation reduces the convulsive expression and amino acid release in the hippocampus during pilocarpine-induced status epilepticus in rats. Epilepsy & Behavior : E&B. 49: 33-9. PMID 26006058 DOI: 10.1016/j.yebeh.2015.04.037 |
0.734 |
|
| 2015 |
Di Ianni ME, Enrique AV, Del Valle ME, Aldana B, Rosella MA, Rocha L, Castro EA, Bruno-Blanch LE, Talevi A. Is there a relationship between sweet taste and seizures? Anticonvulsant and proconvulsant effects of non-nutritive sweeteners. Combinatorial Chemistry & High Throughput Screening. 18: 335-45. PMID 25747439 DOI: 10.2174/1386207318666150305154210 |
0.34 |
|
| 2015 |
Lazarowski A, Czornyj L, Rocha L. The complexity of roles of P-glycoprotein in refractory epilepsy: Pharmacoresistance, epileptogenesis, SUDEP and relapsing marker after surgical treatment Admet and Dmpk. 3: 110-121. DOI: 10.5599/Admet.3.2.162 |
0.446 |
|
| 2015 |
Santana-Gómez CE, Alcántara-González D, Luna-Munguía H, Bañuelos-Cabrera I, Magdaleno-Madrigal V, Fernández-Mas R, Besio W, Rocha L. Transcranial focal electrical stimulation reduces the convulsive expression and amino acid release in the hippocampus during pilocarpine-induced status epilepticus in rats Epilepsy and Behavior. 49: 33-39. DOI: 10.1016/J.Yebeh.2015.04.037 |
0.316 |
|
| 2015 |
Rocha L, Santana-Gómez C, Rosillo-de la Torre A, Magdaleno-Madrigal V, Alonso-Vanegas M, Velasco F, Bruno-Blanch L. Epilepsy Therapeutics Brain Mapping: An Encyclopedic Reference. 3: 887-894. DOI: 10.1016/B978-0-12-397025-1.00105-6 |
0.357 |
|
| 2014 |
Rocha L, Alonso-Vanegas M, Martínez-Juárez IE, Orozco-Suárez S, Escalante-Santiago D, Feria-Romero IA, Zavala-Tecuapetla C, Cisneros-Franco JM, Buentello-García RM, Cienfuegos J. GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors. Frontiers in Cellular Neuroscience. 8: 442. PMID 25601827 DOI: 10.3389/fncel.2014.00442 |
0.338 |
|
| 2014 |
Cuellar-Herrera M, Velasco AL, Velasco F, Trejo D, Alonso-Vanegas M, Nuche-Bricaire A, Vázquez-Barrón D, Guevara-Guzmán R, Rocha L. Alterations of 5-HT1A receptor-induced G-protein functional activation and relationship to memory deficits in patients with pharmacoresistant temporal lobe epilepsy. Epilepsy Research. 108: 1853-63. PMID 25304920 DOI: 10.1016/J.Eplepsyres.2014.09.013 |
0.769 |
|
| 2014 |
Rosillo-de la Torre A, Luna-Bárcenas G, Orozco-Suárez S, Salgado-Ceballos H, GarcÃa P, Lazarowski A, Rocha L. Pharmacoresistant epilepsy and nanotechnology. Frontiers in Bioscience (Elite Edition). 6: 329-40. PMID 24896209 DOI: 10.2741/709 |
0.432 |
|
| 2014 |
Rocha L, Alonso-Vanegas M, Orozco-Suárez S, Alcántara-González D, Cruzblanca H, Castro E. Do certain signal transduction mechanisms explain the comorbidity of epilepsy and mood disorders? Epilepsy & Behavior : E&B. 38: 25-31. PMID 24472685 DOI: 10.1016/j.yebeh.2014.01.001 |
0.376 |
|
| 2013 |
Alvariza S, Fagiolino P, Vázquez M, Rosillo de la Torre A, Orozco Suárez S, Rocha L. Verapamil effect on phenytoin pharmacokinetics in rats. Epilepsy Research. 107: 51-5. PMID 24074542 DOI: 10.1016/j.eplepsyres.2013.09.001 |
0.315 |
|
| 2013 |
Besio W, Cuellar-Herrera M, Luna-Munguia H, Orozco-Suárez S, Rocha L. Effects of transcranial focal electrical stimulation alone and associated with a sub-effective dose of diazepam on pilocarpine-induced status epilepticus and subsequent neuronal damage in rats. Epilepsy & Behavior : E&B. 28: 432-6. PMID 23886585 DOI: 10.1016/J.Yebeh.2013.06.021 |
0.76 |
|
| 2013 |
Auzmendi JA, Orozco-Suárez S, Bañuelos-Cabrera I, González-Trujano ME, González EC, Rocha L, Lazarowski A. P-Glycoprotein Contributes to Cell Membrane Depolarization of Hippocampus and Neocortex in a Model of Repetitive Seizures Induced by Pentylenetetrazole in Rats Current Pharmaceutical Design. 19: 6732-6738. PMID 23530507 DOI: 10.2174/1381612811319380006 |
0.439 |
|
| 2013 |
Rocha L. Interaction between electrical modulation of the brain and pharmacotherapy to control pharmacoresistant epilepsy. Pharmacology & Therapeutics. 138: 211-28. PMID 23353099 DOI: 10.1016/j.pharmthera.2013.01.009 |
0.319 |
|
| 2012 |
Alcantara-Gonzalez D, Floran B, Escartin E, Rocha L. Changes on D2-like receptor induced Gi protein activation and hippocampal dopamine release in kindled rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 40: 246-51. PMID 23085386 DOI: 10.1016/j.pnpbp.2012.10.007 |
0.323 |
|
| 2012 |
Rocha L, Alonso-Vanegas M, Villeda-Hernández J, Mújica M, Cisneros-Franco JM, López-Gómez M, Zavala-Tecuapetla C, Frías-Soria CL, Segovia-Vila J, Borsodi A. Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy Neurobiology of Disease. 45: 499-507. PMID 21964255 DOI: 10.1016/J.Nbd.2011.09.006 |
0.418 |
|
| 2012 |
Cuellar-Herrera M, Velasco AL, Velasco F, Chavez L, Orozco-Suarez S, Armagan G, Turunc E, Bojnik E, Yalcin A, Benyhe S, Borsodi A, Alonso-Vanegas M, Rocha L. Mu opioid receptor mRNA expression, binding, and functional coupling to G-proteins in human epileptic hippocampus. Hippocampus. 22: 122-7. PMID 21049484 DOI: 10.1002/Hipo.20891 |
0.779 |
|
| 2012 |
Luna-Munguía H, Meneses A, Peña-Ortega F, Gaona A, Rocha L. Effects of hippocampal high-frequency electrical stimulation in memory formation and their association with amino acid tissue content and release in normal rats Hippocampus. 22: 98-105. PMID 20882549 DOI: 10.1002/hipo.20868 |
0.452 |
|
| 2011 |
Luna-Munguia H, Orozco-Suarez S, Rocha L. Effects of high frequency electrical stimulation and R-verapamil on seizure susceptibility and glutamate and GABA release in a model of phenytoin-resistant seizures. Neuropharmacology. 61: 807-14. PMID 21645533 DOI: 10.1016/j.neuropharm.2011.05.027 |
0.377 |
|
| 2011 |
Rocha L. Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding. Neuropsychiatric Disease and Treatment. 4: 619-25. PMID 18830436 DOI: 10.2147/ndt.s2118 |
0.413 |
|
| 2010 |
Cuellar-Herrera M, Peña F, Alcantara-Gonzalez D, Neri-Bazan L, Rocha L. Antiepileptic drugs combined with high-frequency electrical stimulation in the ventral hippocampus modify pilocarpine-induced status epilepticus in rats. Epilepsia. 51: 432-7. PMID 19863580 DOI: 10.1111/J.1528-1167.2009.02315.X |
0.756 |
|
| 2009 |
Rocha L, Orozco-Suarez S, Alonso-Vanegas M, Villeda-Hernandez J, Gaona A, Páldy E, Benyhe S, Borsodi A. Temporal lobe epilepsy causes selective changes in mu opioid and nociceptin receptor binding and functional coupling to G-proteins in human temporal neocortex Neurobiology of Disease. 35: 466-473. PMID 19573600 DOI: 10.1016/J.Nbd.2009.06.008 |
0.495 |
|
| 2008 |
Velasco F, Velasco M, Velasco AL, Rocha L, Carrillo-Ruiz JD, Castro G, Cuéllar-Herrera M. [Central nervous system neuromodulation for the treatment of epilepsy. II. Mechanisms of action and perspectives]. Neuro-Chirurgie. 54: 428-35. PMID 18448132 DOI: 10.1016/j.neuchi.2008.02.033 |
0.482 |
|
| 2008 |
Rocha LL. The acute and subchronic pretreatment with antiepileptic drugs modifies the pentylenetetrazol- induced generalized seizures in mice Colombia Medica. 39: 46-50. |
0.363 |
|
| 2007 |
Carmona-Aparicio L, Peña F, Borsodi A, Rocha L. Effects of nociceptin on the spread and seizure activity in the rat amygdala kindling model: their correlations with 3H-leucyl-nociceptin binding. Epilepsy Research. 77: 75-84. PMID 17913464 DOI: 10.1016/j.eplepsyres.2007.08.007 |
0.518 |
|
| 2007 |
Rocha L, Cuellar-Herrera M, Velasco M, Velasco F, Velasco AL, Jiménez F, Orozco-Suarez S, Borsodi A. Opioid receptor binding in parahippocampus of patients with temporal lobe epilepsy: its association with the antiepileptic effects of subacute electrical stimulation. Seizure. 16: 645-52. PMID 17560811 DOI: 10.1016/J.Seizure.2007.05.007 |
0.787 |
|
| 2007 |
Rocha L, Lorigados-Pedre L, Orozco-Suárez S, Morales-Chacón L, Alonso-Vanegas M, García-Maeso I, Villeda-Hernández J, Osorio-Rico L, Estupiñán B, Quintana C. Autoradiography reveals selective changes in serotonin binding in neocortex of patients with temporal lobe epilepsy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 1208-18. PMID 17513030 DOI: 10.1016/j.pnpbp.2007.04.014 |
0.392 |
|
| 2007 |
López-Meraz ML, Martínez A, Rocha L. Effect of 8-OH-DPAT on electrographic activity during the kainic acid-induced status epilepticus in rats. Seizure-European Journal of Epilepsy. 16: 365-370. PMID 17391992 DOI: 10.1016/J.Seizure.2007.02.009 |
0.504 |
|
| 2006 |
López-Meraz ML, Neri-Bazán L, Rocha L. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study. Journal of Pharmacy and Pharmacology. 58: 1243-1248. PMID 16945183 DOI: 10.1211/Jpp.58.9.0011 |
0.377 |
|
| 2006 |
Cuellar-Herrera M, Neri-Bazan L, Rocha LL. Behavioral effects of high frequency electrical stimulation of the hippocampus on electrical kindling in rats. Epilepsy Research. 72: 10-7. PMID 16919422 DOI: 10.1016/j.eplepsyres.2006.07.002 |
0.782 |
|
| 2006 |
Rocha L, Arida RM, Carvalho Rde A, Scorza FA, Neri-Bazan L, Cavalheiro EA. GABA and opioid binding distribution in the brain of the seizure-resistant Proechimys guyannensis: an autoradiography study. Synapse (New York, N.Y.). 60: 392-8. PMID 16847947 DOI: 10.1002/syn.20312 |
0.396 |
|
| 2005 |
Ramírez MG, Suárez SO, Ceballos HS, Velasco AF, Rocha L. Hyperthermia-Induced Seizures Modify the GABAA and Benzodiazepine Receptor Binding in Immature Rat Brain Cellular and Molecular Neurobiology. 27: 211-227. PMID 16802192 DOI: 10.1007/S10571-006-9094-0 |
0.499 |
|
| 2005 |
López-Meraz ML, González-Trujano ME, Neri-Bazán L, Hong E, Rocha LL. 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology. 49: 367-75. PMID 15993434 DOI: 10.1016/j.neuropharm.2005.03.020 |
0.536 |
|
| 2004 |
López-Meraz ML, Neri-Bazán L, Rocha L. Low frequency stimulation modifies receptor binding in rat brain. Epilepsy Research. 59: 95-105. PMID 15246114 DOI: 10.1016/J.Eplepsyres.2004.02.005 |
0.486 |
|
| 2004 |
Cuéllar-Herrera M, Velasco M, Velasco F, Velasco AL, Jiménez F, Orozco S, Briones M, Rocha L. Evaluation of GABA system and cell damage in parahippocampus of patients with temporal lobe epilepsy showing antiepileptic effects after subacute electrical stimulation. Epilepsia. 45: 459-66. PMID 15101827 DOI: 10.1111/J.0013-9580.2004.43503.X |
0.481 |
|
| 2002 |
Pérez-Cruz C, Rocha L. Kainic acid modifies mu-receptor binding in young, adult, and elderly rat brain. Cellular and Molecular Neurobiology. 22: 741-753. PMID 12585692 DOI: 10.1023/A:1021861108885 |
0.42 |
|
| 2002 |
Ondarza R, Trejo-Martínez D, Corona-Amézcua R, Briones M, Rocha L. Evaluation of Opioid Peptide and Muscarinic Receptors in Human Epileptogenic Neocortex: An Autoradiography Study Epilepsia. 43: 230-234. PMID 12121327 DOI: 10.1046/J.1528-1157.43.S.5.27.X |
0.474 |
|
| 2001 |
Velasco F, Velasco M, Velasco AL, Menez D, Rocha L. Electrical stimulation for epilepsy: stimulation of hippocampal foci. Stereotactic and Functional Neurosurgery. 77: 223-7. PMID 12378080 DOI: 10.1159/000064610 |
0.517 |
|
| 2001 |
Cano-Martı́nez A, Villalobos-Molina R, Rocha L. Effects of chronic morphine and N6-cyclopentyl-adenosine administration on kainic acid-induced status epilepticus Epilepsy Research. 44: 89-96. PMID 11325565 DOI: 10.1016/S0920-1211(01)00187-5 |
0.469 |
|
| 2000 |
Rocha L, González‐Trujano ME, Jiménez G, Gaona A, Ondarza R. Characterization of Benzodiazepine Receptor Binding in Immature Rat Brain After Kainic Acid Administration Epilepsia. 41. PMID 10999518 DOI: 10.1111/J.1528-1157.2000.Tb01555.X |
0.425 |
|
| 1999 |
Rocha L, Cano A, Cruz C, Omaña-Zapata I, Villalobos R, Maidment NT. Opioid peptide systems following a subconvulsant dose of pentylenetetrazol in rats. Epilepsy Research. 37: 141-50. PMID 10510980 DOI: 10.1016/S0920-1211(99)00056-X |
0.402 |
|
| 1999 |
Rocha L, Ondarza-Rovira R. Characterization of benzodiazepine receptor binding following kainic acid administration: an autoradiography study in rats Neuroscience Letters. 262: 211-214. PMID 10218893 DOI: 10.1016/S0304-3940(99)00080-4 |
0.483 |
|
| 1997 |
Rocha LL, Evans CJ, Maidment NT. Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis. Journal of Neurochemistry. 68: 616-24. PMID 9003048 DOI: 10.1046/J.1471-4159.1997.68020616.X |
0.445 |
|
| 1996 |
Rocha L, Briones M, Ackermann RF, Anton B, Maidment NT, Evans CJ, Engel J. Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Research. 26: 105-13. PMID 8985692 DOI: 10.1016/S0920-1211(96)00046-0 |
0.455 |
|
| 1996 |
Rocha L, Ackermann RF, Engel J. Chronic and single administration of pentylenetetrazol modifies benzodiazepine receptor-binding: an autoradiographic study. Epilepsy Research. 24: 65-72. PMID 8796354 DOI: 10.1016/0920-1211(95)00104-2 |
0.41 |
|
| 1996 |
Rocha L, Ackermann RF, Engel J. Effects of chronic morphine pretreatment on amygdaloid kindling development, postictal seizure and suppression and benzodiazepine receptor binding in rats. Epilepsy Research. 23: 225-233. PMID 8739125 DOI: 10.1016/0920-1211(95)00103-4 |
0.537 |
|
| 1994 |
Rocha L, Ackermann RF, Chugani HT, Engel J. Chronic pretreatment with naloxone modifies benzodiazepine receptor binding in amygdaloid kindled rats. Epilepsy Research. 17: 135-43. PMID 8194509 DOI: 10.1016/0920-1211(94)90013-2 |
0.534 |
|
| 1992 |
Engel J, Rocha LL. Interictal behavioral disturbances: a search for molecular substrates. Epilepsy Research. Supplement. 9: 341-9; discussion 35. PMID 1337448 |
0.401 |
|
| Show low-probability matches. |